|
|
|
| home > pmps > current issue |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Modern Manufacturing
Five Ways AR is Revolutionising the Manufacturing Industry
A few years ago, AR was a near impossibility, but now it is a thing of reality, and Patrick Liddy at UtilityAR illustrates the benefits this is having on the workforce and in the manufacturing industry.
|
|
|
|
Cleanrooms and Sterilisation
The Hygiene Regime
To reduce the risks of contamination, cleanroom areas and staff have to be kept as hygienic as possible, and Sue Springett at Teknomek illustrates how to maintain this sterile environment.
|
|
|
|
Q&A: Academia-Industry Collaborations
Advancing Pharmaceutical R&D
David Harris, Dr Hugh Smyth, Dr Joanne Peart, and Dr David Lewis at Chiesi debate and discuss the dynamic relationship between universities and the pharmaceutical industry in a Q&A with PMPS.
|
|
|
|
Spotlight
Taking Our Breath Away
H&T Presspart discuss their new respiratory device, eMDI™, which aims to help patients with inhalation adherence so they can lead healthier lives.
|
|
|
|
Adapting to EU Regulations
Regulation, Regulation, Regulation
Elizma Parry at Maetrics examines legislation surrounding medical device regulations adopted in 2017 and the upheaval this may cause for those in the industry developing companion diagnostics or combination products.
|
|
|
|
Track and Trace Technologies
A Vision of Full Integration
Federico Piutti at Bormioli Pharma supports the trend towards more digital technologies and serialisation in the supply chain, as he believes these technologies will allow for a safer supply of drugs to patients.
|
|
|
|
Smart Manufacturing
The Challenges in Starting 4.0 Projects
Denis Decubber at SalamanderU evaluates the current phenomenon of smart industry technology in manufacturing processes, from pharma 4.0 to smart manufacturing and fill and finish.
|
|
|
|
Industry Insight
Randice Altschul, PMPS’s Industry Advisor, comments on articles
within this edition, with a primary focus on cold chain processes,
innovations in labelling, and the Asian pharma market.
|
|
|
|
|
|
Label Translation Accuracy
Translation: An Art, Not a Science
Mike Hunter at Better Languages examines the complexities of label translation on
medicinal products and the ramifications that may occur if mistakes are made.
|
|
|
|
IoT Applications
A Revolution for Supply Chains
Nurdan Citamak at Faubel Pharma Services writes on the complex and demand-driven supply chain, and how innovative smart labels coupled with IoT technologies can help save time as well as money.
|
|
|
|
Evolutions in Pharma Packaging
Preparing for Change
The pharmaceutical packaging industry is always aiming to advance, and Dexter Tjoa at Tjoapack analyses the role of technology that helps facilitate these trends.
|
|
|
|
Label Translation Challenges
Lost in Translation
It is important to know the labelling requirements of your destination country when exporting products internationally, and Alison Senyi at Nexreg Compliance discusses the difficulties of this for companies that seek to find the perfect translation.
|
|
|
|
|
|
Regional Focus: Asia
Exploring Asia
The biggest continent also wants to be the biggest pharmaceutical market in the world. Zdeněk Pečený writes on Asia’s pro-innovation and pro-biotechnology trends that may allow this vision to become a reality.
|
|
|
|
CMOs in Asia
When is a CMO not a CMO?
Hugh Williams at EFESO Consulting examines the role of CMOs in Asia, discerning that they need to change fundamentally if they wish to survive and thrive in the modern supply chain industry.
|
|
|
|
|
|
Spotlight
Ensuring a Seamless Cool Chain
PMPS sits down with Guillaume Halleux at Qatar Airways Cargo, discussing the cold chain industry in which it operates and the methods it uses to ensure the successful delivery of its temperature-sensitive products.
|
|
|
|
Pharma Cold Chain
The Impact of Emerging Trends
Dr Ruediger Lomb at World Courier examines the pharmaceutical cold chain, noting the trend towards more high-precision, low-volume therapies, but also the negative trend of growing prices.
|
|
|
|
Airport Ground Handling
Hurdles in Cold Chain
No part of the cold chain process from manufacturer to end user is unimportant, and Paul Cheng at Hactl examines perhaps one of the most important aspects: ground handling at airports.
|
|
|
|
Transforming Biopharma Cold Chains
Reliable Temperature Control
Sujan Thanjavuru at Clinical Data and SafeRxp theorises about how the cold chain can better cope with temperature excursions, which cost the industry $16 billion in economic losses every year.
|
|
|
|
Spotlight
The ROI of Real-Time Supply Chain Visibility
Discover Controlant’s new real-time supply monitoring solutions, helping aid the entire cold chain from manufacturer through to last-mile and end user.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics
• Collaboration to accelerate development and manufacturing of Bispecific Antibody
• Merck plans to offer Phanes a full suite of products and services under its BioReliance® offering
More info >> |
|
 |
White Papers |
 |
|
Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody
RSSL
Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >> |
|
 |
Industry Events |
 |
SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)
11-13 May 2020, Copthorne Tara Hotel, London, UK
SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >> |
|
|
